Civil Services Chronicle Online March 2020 :
- The Invest India Business Immunity Platform (BIP) is working 24X7 as a comprehensive resource to help businesses and investors get real-time updates on India’s active response to COVID-19 (Coronavirus).
- With no specific treatment available for novel coronavirus disease and a vaccine, recently, the US Food and Drug Administration (FDA) last week approved use convalescent plasma therapy to treat severely critical COVID-19 patients.
- Scientists from Agharkar Research Institute (ARI), Pune, an autonomous institute under the Department of Science & Technology, Government of India, have developed a biofortified durum wheat variety MACS 4028, which shows high protein content.
- As the number of coronavirus cases in India increases, authorities in different states are relying on contact tracing, a concept in epidemiology (the study of the distribution and determinants of health-related states or events).
On 21st March, 2020, the Union Cabinet approved the Modified Electronics Manufacturing Clusters (EMC2.0) Scheme.
On 20th March, 2020, Defence Ministry unveiled the draft Defence Procurement Procedure (DPP) 2020 that aims at further increasing indigenous manufacturing and reducing timelines for procurement of defence equipment.
New 15 point Programme for minorities is a programme launched by Indian government for welfare of religious minorities in furtherance of reports by committees such as the Sachar Committee Report.